This workshop spotlights the development and application of innovative diagnostic technologies and brings together leaders from startups, researchers, and clinicians to explore collaborative strategies for building the next generation of diagnostic tools.
What you’ll learn and discuss:
How quantum-based materials and advanced platforms enable ultrasensitive disease detection.
The integration of real-time biosensing technologies with clinical data pipelines.
The vital role of clinicians in defining needs, validating prototypes, and driving early adoption.
Practical strategies for translating technologies from the lab to the clinic in a patient-centered, scalable way.
The session blends company presentations, clinician insights, and a moderated panel discussion to uncover actionable pathways for closer collaboration between innovators and frontline healthcare providers. Attendees will leave with ideas and connections to help turn diagnostic concepts into real-world solutions.
Facilitators/Speakers:
Moderator: Jennifer Reid- Director, Alberta Diagnostics Ecosystem Platform for Translation (ADEPT)
Applied Quantum Materials (AQM): Dr. Dorra Gargouri- Nano-bio research scientist / Innovations in nanomaterials for biosensing and diagnostics
BioStream Diagnostics: John Murphy- CEO / Lab quality testing from home
Pavonis: Dr. Todd McMullen–CEO/ Innovative Diagnostic platforms and clinician engagement
Clinician Insights: Prof. Richard Fahlman/ Defining real-world needs and adoption barriers
Who should attend:
Clinicians and physician-scientists
Academic researchers and scientists
Healthcare technology startups and innovators
Biotech and med-tech companies
Hospital innovation hubs and clinical trials units
Investors and venture builders in health-tech
Policy makers and health system leaders
Location
Edmonton Unlimited
10107 Jasper Ave, Edmonton, AB T5J 1W8, Canada
Program Room